ArticleClinical mass spectrometry (Del Mar, Calif.)2016
Development of a prototype blood fractionation cartridge for plasma analysis by paper spray mass spectrometry.
Article in Clinical mass spectrometry (Del Mar, Calif.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Clinical Chemistry for Developing Countries: Mass Spectrometry.Annual review of analytical chemistry (Palo Alto, Calif.) · 2021Review
- Microfluidic-based approaches for COVID-19 diagnosis.Biomicrofluidics · 2020Review
- Rapid and quantitative determination of fentanyls and pharmaceuticals from powdered drug samples by paper spray mass spectrometry.Analytical science advances · 2020Article
- Emerging trends in paper spray mass spectrometry: Microsampling, storage, direct analysis, and applications.Mass spectrometry reviews · 2020Review
- Using Sesame Seed Oil to Preserve and Preconcentrate Cannabinoids for Paper Spray Mass Spectrometry.Journal of the American Society for Mass Spectrometry · 2020Article
- Direct sampling mass spectrometry for clinical analysis.The Analyst · 2019Review
- MS-Based Analytical Techniques: Advances in Spray-Based Methods and EI-LC-MS Applications.Journal of analytical methods in chemistry · 2018Review
Corrections and comments
- Erratum issued
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug monitoring of biofluids is often time consuming and prohibitively expensive. Analysis of dried blood spots offers advantages, such as reduced sample volume, but depends on extensive sample preparation and the presence of a trained lab technician. Paper spray mass spectrometry allows rapid analysis of small molecules from blood spots with minimal sample preparation, however, plasma is often the preferred matrix for bioanalysis. Plasma spots can be analyzed by paper spray MS, but a centrifugation step to isolate the plasma is required. We demonstrate here the development of a paper spray cartridge containing a plasma fractionation membrane to perform automatic on-cartridge plasma fractionation from whole blood samples. Three commercially available blood fractionation membranes were evaluated based on: 1) accuracy of drug concentration determination in plasma, and 2) extent of cell lysis and/or penetration. The accuracy of drug concentration determination was quantitatively determined using high performance liquid chromatography-mass spectrometry (HPLC-MS). While the fractionation membranes were capable of yielding plasma samples with low levels of cell lysis, the membranes did exhibit drug binding to varying degrees, as indicated by a decrease in the drug concentration relative to plasma obtained by centrifugation. Using the membrane exhibiting the lowest binding, we developed a composite paper spray cartridge incorporating the selected fractionation membrane. Quantitative analysis of the plasma samples by paper spray MS yielded results similar to those found with HPLC-MS, but without the need for offline extraction or chromatography.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.